The role of metabolic plasticity of tumor-associated macrophages in shaping the tumor microenvironment immunity

MN Hasan, O Capuk, SM Patel, D Sun - Cancers, 2022 - mdpi.com
Simple Summary Tumor associated macrophages (TAMs) support disease progression by
providing tumor cells cytokines and chemokines necessary for malignant growth and …

Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential

YL Xiao, Y Gong, YJ Qi, ZM Shao… - Signal Transduction and …, 2024 - nature.com
Diet, serving as a vital source of nutrients, exerts a profound influence on human health and
disease progression. Recently, dietary interventions have emerged as promising adjunctive …

Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis

JJA Saab, LN Dzierozynski, PB Jonker, R AminiTabrizi… - Elife, 2023 - elifesciences.org
Nutrient stress in the tumor microenvironment requires cancer cells to adopt adaptive
metabolic programs for survival and proliferation. Therefore, knowledge of …

Cystine deprivation triggers CD36-mediated ferroptosis and dysfunction of tumor infiltrating CD8+ T cells

C Han, M Ge, P Xing, T Xia, C Zhang, K Ma, Y Ma… - Cell Death & …, 2024 - nature.com
Cancer cells develop multiple strategies to evade T cell-mediated killing. On one hand,
cancer cells may preferentially rely on certain amino acids for rapid growth and metastasis …

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy

X Dong, S Xia, S Du, MH Zhu, X Lai, SQ Yao… - ACS Central …, 2023 - ACS Publications
Cancer immunotherapy has become an established therapeutic paradigm in oncologic
therapy, but its therapeutic efficacy remains unsatisfactory in the majority of cancer patients …

OATD-02 validates the benefits of pharmacological inhibition of arginase 1 and 2 in cancer

MM Grzybowski, PS Stańczak, P Pomper, R Błaszczyk… - Cancers, 2022 - mdpi.com
Simple Summary Arginase 1 and 2 are drivers of multiple immunosuppressive mechanisms
and tumour-specific metabolic adaptations. Pharmacological inhibition of extracellular ARG1 …

4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells

J Swatler, L Turos-Korgul… - Blood …, 2022 - ashpublications.org
Chronic and acute myeloid leukemia evade immune system surveillance and induce
immunosuppression by expanding proleukemic Foxp3+ regulatory T cells (Tregs). High …

[HTML][HTML] Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment

K Laubach, T Turan, R Mathew… - Cancer Drug …, 2023 - ncbi.nlm.nih.gov
The development of immune checkpoint blockade (ICB) therapies has been instrumental in
advancing the field of immunotherapy. Despite the prominence of these treatments, many …

Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells

TM Grzywa, A Sosnowska, Z Rydzynska… - Communications …, 2021 - nature.com
Abstract CD71+ erythroid cells (CECs) have been recently recognized in both neonates and
cancer patients as potent immunoregulatory cells. Here, we show that in mice early-stage …

Impact of tumor microenvironment on adoptive T cell transfer activity

C Martín-Otal, F Navarro, N Casares… - International Review of …, 2022 - Elsevier
Recent advances in immunotherapy have revolutionized the treatment of cancer. The use of
adoptive cell therapies (ACT) such as those based on tumor infiltrating lymphocytes (TILs) or …